Plasminogen activator inhibitor-1 (PAI-1) 4G5G polymorphism and PAI-1 enzyme activity in young patients with ischemic stroke

被引：0
|
作者：
Santos, M. S. [1 ]
Sabino, A. P. [1 ]
Carvalho, M. G. [1 ]
Ribeiro, D. D. [2 ]
Gadelha, T. [2 ]
Dusse, L. S. [2 ]
Fernandes, A. P. [1 ]
机构：
[1] Univ Fed Minas Gerais, Clin & Toxicol Anal, Belo Horizonte, MG, Brazil
[2] Clin Hosp, Clin & Toxicol Anal, Belo Horizonte, MG, Brazil
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-MO-334
引用
收藏
页码：431 / 431
页数：1
相关论文
共 50 条
  • [31] The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
    Malik Ejder Yıldırım
    Savas Karakuş
    Hande Küçük Kurtulgan
    Hasan Kılıçgün
    Serpil Erşan
    Sevtap Bakır
    Biochemical Genetics, 2017, 55 : 314 - 321
  • [32] DAYTIME FLUCTUATIONS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN POPULATIONS WITH HIGH PAI-1 LEVELS
    JUHANVAGUE, I
    ALESSI, MC
    RACCAH, D
    AILLAUD, MF
    BILLEREY, M
    ANSALDI, J
    PHILIPJOET, C
    VAGUE, P
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 76 - 82
  • [33] THE ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) OF HUMAN PLATELET
    BOOTH, NA
    CROLL, A
    BENNETT, B
    FIBRINOLYSIS, 1990, 4 : 138 - 140
  • [34] The plasminogen activator inhibitor-1 (PAI-1) gene −844 A/G and −675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome
    Sun Lin
    Zhang Huiya
    Liu Bo
    Wei Wei
    Guan Yongmei
    Endocrine, 2009, 36 : 503 - 509
  • [35] ELEVATED LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1), 4G/5G PROMOTER POLYMORPHISM AND THE DEVELOPMENT OF ATHEROTHROMBOTIC AND HEMORRHAGIC STROKE
    CATTO, AJ
    CARTER, AM
    STICKLAND, MH
    BAMFORD, J
    DAVIES, JA
    GRANT, PJ
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1399 - 1399
  • [36] The 4G/5G polymorphism of the plasminogen activator inhibitor 1 (PAI-1) gene and thrombosis in patients with antiphospholipid syndrome
    Mukhametova, L., I
    Gulin, D. A.
    Aisina, R. B.
    Reshetnyak, T. M.
    Ostryakova, E., V
    Seredavkina, N., V
    Patrusheva, N. L.
    Patrushev, L., I
    Aleksandrova, E. N.
    Gershkovich, K. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 418 - 419
  • [37] Acute-phase levels of plasminogen activator inhibitor-1 (PAI-1) and the 4G/5G PAW promoter polymorphism
    Andreotti, F
    Burzotta, F
    Di Castelnuovo, A
    Schiavello, R
    Donati, MB
    Maseri, A
    Possati, GF
    Iacoviello, L
    EUROPEAN HEART JOURNAL, 2002, 23 : 672 - 672
  • [38] Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G/5G polymorphism of the PAI-1 gene
    Nordt, TK
    Eschenfelder, E
    Peter, K
    Sobel, BE
    Bode, C
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (01) : 36 - 42
  • [39] Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis A meta-analysis
    Bae, S-C
    Lee, Y. H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 312 - 318
  • [40] Plasminogen-activator inhibitor-1 in (PAI-1) gastric cancer
    Tabuchi, Y
    Nakamura, T
    Miyamura, K
    Nakae, S
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 447 - 450
12345